Pennsylvania HB 2158: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances.

Bill Text

PRINTER'S NO. 2792
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No. 2158
Session of
2026
INTRODUCED BY DAY, KUZMA, PUGH, WALSH, SHAFFER, ZIMMERMAN AND
HEFFLEY, JANUARY 23, 2026
REFERRED TO COMMITTEE ON JUDICIARY, JANUARY 26, 2026
AN ACT
Amending the act of April 14, 1972 (P.L.233, No.64), entitled
"An act relating to the manufacture, sale and possession of
controlled substances, other drugs, devices and cosmetics;
conferring powers on the courts and the secretary and
Department of Health, and a newly created Pennsylvania Drug,
Device and Cosmetic Board; establishing schedules of
controlled substances; providing penalties; requiring
registration of persons engaged in the drug trade and for the
revocation or suspension of certain licenses and
registrations; and repealing an act," further providing for
schedules of controlled substances.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Section 4(1) of the act of April 14, 1972
(P.L.233, No.64), known as The Controlled Substance, Drug,
Device and Cosmetic Act, is amended by adding a subclause to
read:
Section 4. Schedules of Controlled Substances.--The
following schedules include the controlled substances listed or
to be listed by whatever official name, common or usual name,
chemical name, or trade name designated.
(1) Schedule I--In determining that a substance comes within
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22

this schedule, the secretary shall find: a high potential for
abuse, no currently accepted medical use in the United States,
and a lack of accepted safety for use under medical supervision.
The following controlled substances are included in this
schedule:
* * *
(ix) Any material, compound, mixture or preparation that
contains 7-hydroxymitragynine in a concentration equal to or
exceeding 2% of the total alkaloid content or 1 milligram per
recommended serving size, or any synthetic, semi-synthetic or
chemically manipulated form of mitragynine, 7-
hydroxymitragynine, mitragynine pseudoindoxyl or any other
synthetic, semi-synthetic or chemically manipulated alkaloid,
metabolite, derivative or analogue of the Mitragyna speciosa
plant.
* * *
Section 2. This act shall take effect in 60 days.
20260HB2158PN2792 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17